Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-08-24 4:48 pm Sale | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 79,180,922 78.6% | -518,046 (-0.65%) | View |
| 2023-04-12 4:05 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 79,698,968 78.8% | 273,813 (+0.34%) | View |
| 2023-03-22 4:16 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 79,425,155 78.7% | 12,773,002 (+19.16%) | View |
| 2023-02-17 07:01 am Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 66,652,153 75.6% | 9,570,743 (+16.77%) | View |
| 2023-01-27 4:01 pm Sale | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 57,081,410 72.6% | -7,116,039 (-11.08%) | View |
| 2022-12-15 4:06 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 64,197,449 74.9% | 4,758,470 (+8.01%) | View |
| 2022-10-25 4:05 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 59,438,979 73.4% | 3,895,525 (+7.01%) | View |
| 2022-08-23 4:11 pm Sale | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 55,543,454 72.1% | -1,031,844 (-1.82%) | View |
| 2022-06-24 4:17 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 56,575,298 72.5% | 10,701,834 (+23.33%) | View |
| 2022-04-11 4:16 pm Sale | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 45,873,464 68.1% | -2,998,333 (-6.14%) | View |
| 2022-02-22 4:16 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 48,871,797 69.5% | 9,380,260 (+23.75%) | View |
| 2022-02-14 4:40 pm Sale | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 39,491,537 64.8% | -4,756,168 (-10.75%) | View |
| 2021-12-13 4:16 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 44,247,705 67.3% | 7,621,441 (+20.81%) | View |
| 2021-11-18 4:15 pm Unchanged | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 36,626,264 63% | 0 (Unchanged) | View |
| 2021-11-02 4:15 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 36,626,264 63% | 3,795,380 (+11.56%) | View |
| 2021-09-14 4:17 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 32,830,884 60.4% | 4,071,286 (+14.16%) | View |
| 2021-05-26 4:15 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 28,759,598 57.2% | 1,281,204 (+4.66%) | View |
| 2021-05-11 4:17 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 27,478,394 56.1% | 3,778,640 (+15.94%) | View |
| 2021-02-17 4:40 pm Purchase | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 23,699,754 52.7% | 168,727 (+0.72%) | View |
| 2021-02-09 4:15 pm Sale | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 23,531,027 52.6% | -128,134 (-0.54%) | View |